{"id":"W2191511762","doi":"10.1158/1078-0432.ccr-15-1349","title":"Gemtuzumab Ozogamicin Reduces Relapse Risk in <i>FLT3</i> /ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group","year":2015,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Gemtuzumab ozogamicin; Medicine; Oncology; Myeloid leukemia; Internal medicine; Leukemia; Calicheamicin; Biology; CD33","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008272929,0.0002135053,0.000269808,0.0001400217,0.00007536174,0.000248901,0.0001403405,0.0001664819,0.0003881344],"category_scores_gemma":[0.0008819737,0.00005757945,0.0004346991,0.0001526015,0.0001804632,0.0001189757,0.0001025137,0.0005099448,0.00005130704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005251147,"about_ca_system_score_gemma":0.0003275796,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00135867,"about_ca_topic_score_gemma":0.002572809,"domain_scores_codex":[0.9998322,0.00007296186,0.00001464116,0.00002525352,0.00003386795,0.00002108628],"domain_scores_gemma":[0.9997153,0.0001215664,0.00008146739,0.00002240845,0.00002550113,0.00003372039],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.05074933,0.002597712,0.1525742,0.001135928,0.002604133,0.00036533,0.0002760342,0.00302827,0.07107612,0.000462175,0.009648425,0.7054824],"study_design_scores_gemma":[0.01472431,0.06494026,0.8362821,0.0003303059,0.004428902,0.001902638,0.0001559613,0.00368135,0.04084819,0.0003268233,0.03233656,0.00004265204],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.986032,0.01214222,0.0002515559,0.0006165997,0.00002864054,0.0000593872,0.0002336481,0.0000193948,0.0006165097],"genre_scores_gemma":[0.9933984,0.004687637,0.0005779862,0.0004210401,0.00005918561,0.00003791074,0.000461375,0.000008935095,0.0003474627],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00135867,"threshold_uncertainty_score":0.004375219,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1479212835732433,"score_gpt":0.4890948956744304,"score_spread":0.3411736121011871,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}